Who owns MAIA BIOTECHNOLOGY INC?
- Ticker: MAIA
- CUSIP Number: 552641102
Tip: Access positions for across all investors
Analyze quarterly positions in Maia Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Maia Biotechnology stock
Who bought or sold MAIA BIOTECHNOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Solas Capital Management | 4.3M | $6.0M | 100% | Mar 2026 |
|
| Alyeska Investment Group | 2.5M | $3.5M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 2.1M | $2.9M | 100% | Mar 2026 |
|
| Vanguard Group | 1.2M | $1.8M | 5% | Dec 2025 |
|
| 683 Capital Management | 1.1M | $1.5M | 100% | Mar 2026 |
|
| Centric Wealth Management | 797k | $1.1M | 36% | Mar 2026 |
|
| Cable Car Capital | 649k | $908k | 100% | Mar 2026 |
|
| Bleichroeder | 500k | $700k | 100% | Mar 2026 |
|
| Geode Capital Management | 361k | $505k | 21% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 199k | $279k | 100% | Mar 2026 |
|
| State Street Corporation | 139k | $195k | 84% | Mar 2026 |
|
| BlackRock | 128k | $179k | 19% | Mar 2026 |
|
| Corsair Capital Management | 100k | $140k | 100% | Mar 2026 |
|
| Northern Trust | 53k | $74k | 35% | Mar 2026 |
|
| UBS Group | 52k | $73k | 2292% | Mar 2026 |
|
| Bridgeway Capital Management | 36k | $50k | 0% | Mar 2026 |
|
| Pvg Asset Management | 34k | $46k | 100% | Mar 2026 |
|
| Creative Planning | 29k | $40k | -1% | Mar 2026 |
|
| Comprehensive Portfolio Management | 23k | $32k | 0% | Mar 2026 |
|
| O'shaughnessy Asset Management | 20k | $28k | 100% | Mar 2026 |
|
| Centerpoint Advisory Group | 16k | $22k | 0% | Mar 2026 |
|
| Morgan Stanley | 14k | $19k | 1286% | Mar 2026 |
|
| Vanguard Global Advisers | 11k | $16k | 100% | Mar 2026 |
|
| Catalyst Funds Management Pty | 11k | $15k | 100% | Mar 2026 |
|
| Cambridge Investment Research Advisors | 11k | $15k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 8.3k | $12k | 0% | Mar 2026 |
|
| Daytona Street Capital | 7.5k | $10k | 100% | Mar 2026 |
|
| Curio Wealth | 2.0k | $2.8k | 0% | Mar 2026 |
|
| MAI Wealth Advisors | 675.00 | $945.000000 | 0% | Mar 2026 |
|
| Tucker Asset Management | 341.00 | $522.002800 | 100% | Dec 2025 |
|
| Royal Bank of Canada | 268.00 | $0 | 100% | Mar 2026 |
|
| Jones Financial Companies, L.L | 228.00 | $298.999200 | 0% | Mar 2026 |
|
| Citigroup | 22.00 | $31.000200 | 100% | Mar 2026 |
|
| FMR | 2.00 | $2.000000 | 100% | Mar 2026 |
|
Who sold out of Maia Biotechnology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Dec 2025 | 79k | $121k |
| Wealth Enhancement Advisory Services | Dec 2025 | 15k | $23k |
| Susquehanna International | Dec 2025 | 14k | $22k |
| Intl Fcstone | Dec 2025 | 10k | $16k |
| Rocky Mountain Advisers | Dec 2025 | 653.00 | $999.024700 |